Current Medical Research and Opinion

Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK
pp. 817-826(10)
Authors: Guest, Julian F.; Davie, Alison M.; Clegg, John P.

Variability of fine particle dose and lung deposition of budesonide delivered through two multidose dry powder inhalers
pp. 827-834(8)
Authors: Munzel, U.; Marschall, K.; Fyrnys, B.; Wedel, M.

Is it possible to make cross-study comparisons of urinary continence rates in patients with overactive bladder?
pp. 835-838(4)
Authors: Staskin, David R.; Wein, Alan

Management of hypertension and hypercholesterolaemia in primary care in the Netherlands
pp. 839-848(10)
Authors: van Wyk, Jacobus T.; Picelli, Gino; Dieleman, Jeanne P.; Mozaffari, Essy; Kramarz, Piotr; van Wijk, Marc A.M.; van der Lei, Johan; Sturkenboom, Miriam C.J.M.

An observational study of health-related quality of life and pain outcomes in chronic low back pain patients treated with fentanyl transdermal system
pp. 849-862(14)
Authors: Kosinski, Mark R.; Schein, Jeff R.; Vallow, Sue M.; Ascher, Steven; Harte, Clare; Shikiar, Richard; Frank, Lori; Margolis, Mary Kay; Vorsanger, Gary

Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting β2-agonists: addition of montelukast in an open-label pilot study
pp. 863-870(8)
Authors: Dupont, Lieven; Potvin, Emmanuel; Korn, Dana; Lachman, Albert; Dramaix, Michèle; Gusman, Julie; Peché, Rudi

The cognitive effects of cholinesterase inhibitor treatment in every-day practice
pp. 871-876(6)
Authors: Kapaki, E.; Paraskevas, G.P.

A pilot study comparing the purity, functionality and isoform composition of alpha-1-proteinase inhibitor (human) products
pp. 877-884(8)
Authors: Cowden, D.I.; Fisher, G.E.; Weeks, R.L.

Optimising antiemetic therapy: what are the problems and how can they be overcome?
pp. 885-898(14)
Author: Aapro, Matti

Comparative analytical characterization of two commercial human follicle-stimulating hormones extracted from human urine
pp. 899-906(8)
Authors: Bassett, R.; Ceccarelli, D.; Crisci, C.; di Tria, A.M.; Mancinelli, M.; Martelli, F.; Mendola, D.; Pezzotti, A.

Effect of bosentan treatment on surrogate markers in pulmonary arterial hypertension
pp. 907-912(6)
Authors: Souza, Rogerio; Jardim, Carlos; Martins, Bárbara; Cortopassi, Felipe; Yaksic, Mateo; Rabelo, Rogerio; Bogossian, Humberto

Cost-effectiveness in Italy of preventive treatment with ramipril in patients at high risk of cardiovascular events
pp. 913-922(10)
Authors: Capri, Stefano; Perlini, Stefano

Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies
pp. 923-934(12)
Authors: Vieta, Eduard; Mullen, Jamie; Brecher, Martin; Paulsson, Björn; Jones, Martin

Long-acting blood pressure reduction by candesartan cilexetil in patients with hypertension
pp. 935-940(6)
Authors: Bönner, Gerd; Fuchs, Winfried

Benzodiazepines and anxiety disorders: a review for the practicing physician
pp. 941-950(10)
Authors: Michael Kaplan, Eric; DuPont, Robert L.

Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial
pp. 951-958(8)
Author: Leonetti, G.

The use of ezetimibe in achieving low density lipoprotein lowering goals in clinical practice: position statement of a United Kingdom consensus panel
pp. 959-970(12)
Authors: Mikhailidis, D.P.; Wierzbicki, A.S.; Daskalopoulou, S.S.; Al-Saady, N.; Griffiths, H.; Hamilton, G.; Monkman, D.; Patel, V.; Pittard, J.; Schachter, M.

Safety, tolerability, and exploratory efficacy of montelukast in 6- to 24-month-old patients with asthma
pp. 971-982(12)
Authors: van Adelsberg, Janet; Moy, James; Wei, Lynn X.; Tozzi, Carol A.; Knorr, Barbara; Reiss, Theodore F.